“…Consequently, a number of studies have evaluated ovarian reserve after UAE for symptomatic fibroids using hormone markers and have suggested that ovarian reserve is subclinically affected in most women; however, the ovarian reserve of perimenopausal women 45 years of age and older was apparently affected [7,[12][13][14][15][16][17].There are many markers for evaluating ovarian reserve, including antral follicle count (AFC), anti-Mü llerian hormone (AMH), follicle stimulating hormone (FSH), inhibin B, estradiol (E2), and luteinizing hormone (LH) [18]; however, AMH is superior to these other markers for evaluating ovarian reserve [19,20]. Few reports have evaluated ovarian reserve based on AMH level after UAE [21,22]. Therefore, the aim of the present study was to evaluate the effects of UAE on ovarian reserve, as determined by AMH, in premenopausal women.…”